Realtime Device-Driven Escalation-Avoidance for Heart Failure
Coredio is a SaaS platform that leverages available cardiologist devices used for routine checkups to non-invasively provide central blood pressure (CBP) and cardiac output (CO). Combined with its physics-based AI-assisted proprietary algorithms it helps in detecting early signs of cardiovascular abnormalities and guide personalized therapy.
Coredio is always available for cardiologists and their patients, even when Echo or Catheterization are not.
Product Features
Coredio helps doctors, cardiologists and patients
Realtime Device-Driven Escalation Avoidance for Heart Failure
Coredio is a SaaS platform that leverages available cardiologist devices used for routine checkups to non-invasively provide central blood pressure (CBP) and cardiac output (CO). Combined with its physics-based AI-assisted proprietary algorithms it helps in detecting early signs of cardiovascular abnormalities and guide personalized therapy.
Coredio is always available for cardiologists and their patients, even when Echo or Catheterization are not.
Product Features
Coredio helps doctors, cardiologists and patients
Workflow
About The Platform
Personalized Cardiovascular Monitoring with CoreDio
Patient Eligibility: CoreDio is visioned to be prescribed for patients with cardiovascular abnormality symptoms visiting their cardiologists or for those seeking proactive monitoring due to a family history of cardiovascular conditions, such as heart failure and hypertension.
One-Time Calibration Process: A 20 minutes non-invasive one-time calibration is performed, leveraging the patient’s PPG, ECG, and a few portable ultrasound measurements at specific anatomical points – wrist, arm, and neck. Once calibrated, CoreDio’s precision remains tailored to the individual patient for a subsequent up to 3 years.
On-Demand Monitoring: After one-time calibration, medical professionals can use Coredio platform seamlessly by taking wrist PPG+ECG readings in addition to portable ultrasound or cuff BP to continuous monitor patient’s cBP and CO. The platform’s versatility allows for monitoring within clinical settings, operative rooms, or even remotely. For at-home use Coredio only needs smartwatch sensors and a compatible arm cuff.
Workflow
About The Platform
Personalized Cardiovascular Monitoring with CoreDio
Patient Eligibility: CoreDio is visioned to be prescribed for patients with cardiovascular abnormality symptoms visiting their cardiologists or for those seeking proactive monitoring due to a family history of cardiovascular conditions, such as heart failure and hypertension.
One-Time Calibration Process: A 20 minutes non-invasive one-time calibration is performed, leveraging the patient’s PPG, ECG, and a few portable ultrasound measurements at specific anatomical points – wrist, arm, and neck. Once calibrated, CoreDio’s precision remains tailored to the individual patient for a subsequent up to 3 years.
On-Demand Monitoring: After one-time calibration, medical professionals can use Coredio platform seamlessly by taking wrist PPG+ECG readings in addition to portable ultrasound or cuff BP to continuous monitor patient’s cBP and CO. The platform’s versatility allows for monitoring within clinical settings, operative rooms, or even remotely. For at-home use Coredio only needs smartwatch sensors and a compatible arm cuff.
Accuracy
The Sensitivity Of The Device In Finding Accurate Statistics
Accuracy & Validation
- Validation: Tested at Strong Memorial Hospital
- Standard Comparison: Strong correlation with arm BP and echo
- Precision: Consistent outcome by capturing patient physiology
- Patient Trials: Validated on 10 patients and counting
Future Milestones:
- Regulatory: Preparing for FDA pre-submission.
- Expansion: Awaiting IRB for larger clinical trial.
Accuracy
The Sensitivity Of The Device In Finding Accurate Statistics
Accuracy & Validation
- Validation: Tested at Strong Memorial Hospital
- Standard Comparison: Strong correlation with arm BP and echo
- Precision: Consistent outcome by capturing patient physiology
- Patient Trials: Validated on 10 patients and counting
Future Milestones:
- Regulatory: Preparing for FDA pre-submission.
- Expansion: Awaiting IRB for larger clinical trial.
Testimonials
Testimonials from patients and doctors
Cardiologist #1
Head Cardiologist
By potentially averting re-admission hospitalizations, it not only ensures better patient care but also can result in significant savings – approximately $20k per instance.
Cardiologist #2
Cardiovascular Surgeon
CoreDio can potentially change the way we do transcatheter aortic valve replacement (TAVR). By alleviating burdens and risks, it makes workflow of cardiovascular surgeons easier.
Cardiologist #3
Cardiologist
In our high-volume cardio clinic, where we perform over 100 cath surgeries daily, the immediate value of the CoreDio platform is undeniable. We would integrate it without hesitation if available.
